Zhejiang University Researchers Highlight Research in Multiple Myeloma (The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China)

Prensa/medios de comunicación: !!!Research

Períododic. 30 2022

Cobertura de los medios

1

Cobertura de los medios

  • NombreZhejiang University Researchers Highlight Research in Multiple Myeloma (The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China)
    Nombre/canal del medio de comunicaciónNewsRx Hematology Daily
    País/TerritorioEstados Unidos
    Fecha30/12/22
    PersonasYang Yang